Skip directly to site content Skip directly to page options Skip directly to A-Z link
Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
For a full list of topics: A-Z Index
Advanced Search
Advanced Search
Tuberculosis (TB)
    CDC Home
    • Facebook
    • Twitter
    • LinkedIn
    • Syndicate

    Fact Sheets

    Español (Spanish)
    Minus
    Related Pages

    Testing and Diagnosis

    Testing for TB
    PDF pdf icon[PDF – 287K]

    Testing for TB
    PDF pdf icon[PDF – 306K]

    TB Can Be Treated
    PDF pdf icon[PDF – 334K]

    A New Tool to Diagnose Tuberculosis: The Xpert MTB/RIF Assay
    PDF pdf icon[PDF – 303K]

    Recommendations for Human Immunodeficiency Virus (HIV) Screening in Tuberculosis (TB) Clinics
    PDF pdf icon[PDF – 433K]

    Interferon-Gamma Release Assays (IGRAs) – Blood Tests for TB Infection
    PDF pdf icon[PDF – 180K]

    Tuberculin Skin Testing

    Tuberculin Skin Testing
    PDF pdf icon[PDF – 435K]

    Diagnosis of Tuberculosis Disease
    PDF pdf icon[PDF – 522K]

    Targeted Tuberculosis Testing and Interpreting Tuberculin Skin Test Results
    PDF pdf icon[PDF – 213K]

    Page last reviewed: December 17, 2020
    Content source: Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
    homeTuberculosis
    • Basic TB Factsplus icon
      • How TB Spreads
      • Latent TB Infection and TB Disease
      • Signs & Symptoms
      • TB Risk Factors
      • Exposure to TB
      • TB Prevention
      • Vaccines
      • TB & HIV Coinfection
      • TB and Diabetes
      • TB Terms
    • Personal Storiesplus icon
      • Stories by Topic
      • Archived Stories
    • Testing & Diagnosisplus icon
      • Who Should be Tested
      • Testing for TB Infection
      • Testing in BCG-Vaccinated Persons
      • TB Screening and Testing of Health Care Personnel
      • Testing During Pregnancy
      • Diagnosing latent TB infection and TB disease
    • Treatmentplus icon
      • Deciding When to Treat Latent TB Infection
      • Treatment Regimens for Latent TB Infection (LTBI)
      • Treatment for TB Disease
      • Adverse Events
      • TB Treatment of Persons Living with HIV
      • TB Treatment and Pregnancy
      • TB Treatment for Children
      • Frequently Asked Questions
    • Drug-Resistant TB
    • Researchplus icon
      • TB Epidemiologic Studies Consortiumplus icon
        • Research Projects
        • Publications
      • TB Trials Consortiumplus icon
        • Study Descriptions
        • Background
      • Behavioral & Social Science Research
    • Health Care Settingsplus icon
      • TB Infection Control in Health Care Settings
      • Resources for TB Screening and Testing of Health Care Personnelplus icon
        • Frequently Asked Questions
    • TB in Specific Populationsplus icon
      • Health Disparities
      • Asian Persons
      • Black or African American Persons
      • Hispanic or Latino Persons
      • Children
      • Pregnancy
      • Correctional Facilities
      • People Experiencing Homelessness
      • International Travelers
    • Laboratory Informationplus icon
      • Drug Susceptibility Testing
      • False-Positive Investigation Toolkit
      • Interim Laboratory Biosafety Guidance for XDR Mycobacterium tuberculosis strains
      • Model Performance Evaluation Program (MPEP)
      • Rapid Molecular Testing to Detect Drug-Resistant TB in the USplus icon
        • Executive Summary
        • Introduction
        • Background on Tests for Molecular Detection of DR
        • General Considerations and Principles for a Molecular DR Testing Service
        • Possible Scenarios and Scope of Testing for a Molecular DR Testing Service
        • Research Needs
        • General Recommendations of the Expert Panel
        • Communication Plan for the Report
        • Recommendations
        • References
        • Panel Members and CDC Participants
        • Appendix 1
        • Appendix 2
        • Appendix 3
      • The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TBplus icon
        • General Considerations
        • General Recommendations of the Expert Panel
        • Recommendations to ACET, CDC, DTBE
    • Data & Statisticsplus icon
      • TB Incidence in the United States
      • Reported TB in the US, 2020 Surveillance Report
      • Trends in Tuberculosis 2020
      • Tuberculosis in the United States, 2020 (Slide Set)
      • Archived Surveillance Reports and Slide Sets
      • 2020 State and City Report
      • Archived State and City Reports
    • Professional Resources & Toolsplus icon
      • Tools for Healthcare Providersplus icon
        • Interactive Core Curriculum on Tuberculosis: What the Clinician Should Know
      • Resources for TB Programsplus icon
        • Strengthening Civil Surgeons’ Capacity to Improve LTBI Surveillance and Outcomes Among Status Adjusters
        • Notice of Funding Opportunity (NOFO)
        • Program Evaluation
      • TB Centers of Excellence
      • TB Elimination Alliance
      • TB Genotypingplus icon
        • Conventional TB Genotyping
        • Whole Genome Sequencing
        • TB GIMS
        • Analytic Tools
      • Latent Tuberculosis Infection Resources
    • Publications & Productsplus icon
      • Patient and Public Materials
      • Fact Sheetsplus icon
        • General
        • Data & Statistics
        • Drug-Resistant TB
        • Infection Control & Prevention
        • TB in Specific Populations
        • Treatment
        • Testing & Diagnosis
        • Vaccines & Immunizations
      • Guidelinesplus icon
        • Control & Elimination
        • Drug-Resistant TB
        • Infection Control & Prevention
        • Laboratory & Genotyping
        • TB & HIV
        • TB in Specific Populations
        • Testing & Diagnosis
        • Treatment
        • Vaccines & Immunizations
        • Archived TB Guidelines
      • Guides & Toolkitsplus icon
        • Aggregate Reports
        • CDC TB Surveillance Training
        • Core Curriculum
        • Effective TB Interviewing for Contact Investigation
        • Ethnographic Guides
        • False-Positive Investigation Toolkit
        • Forging Partnerships to Eliminate TB
        • Guide to Application of Genotyping
        • LTBI: A Guide for Primary Health Care Providers
        • Mantoux Tuberculin Skin Testing Products
        • Report of Verified Case of Tuberculosis (RVCT)
        • Self-Study Modules
        • TB Contact Investigation Interviewing Skills Course
        • TB eDOT Toolkit
        • Understanding the TB Cohort Review Process
      • Newslettersplus icon
        • TB Notes, No. 1, 2022
        • TB Notes, No. 4, 2021
        • TB Notes, No. 3, 2021
        • TB Notes, No. 2, 2021
        • TB Notes, No. 1, 2021
        • TB Notes, No. 4, 2020
        • TB Notes, No. 3, 2020
        • TB Notes, No. 2, 2020
        • TB Notes, No. 1, 2020
        • TB Notes, No. 4, 2019
        • TB Notes, No. 3, 2019
        • TB Notes, No. 2, 2019
        • TB Notes, No. 1, 2019
        • TB Notes, No. 6, 2018 
        • TB Notes, No. 5, 2018
        • TB Notes, No. 4, 2018
        • TB Notes, No. 3, 2018
        • TB Notes, No. 2, 2018
        • TB Notes, No. 1, 2018
        • TB Notes, No. 5, 2017
        • TB Notes, No. 4, 2017
        • TB Notes, No. 3, 2017
        • TB Notes, No. 2, 2017
        • TB Notes, No. 1, 2017
        • TB Notes, No. 5, 2016
        • TB Notes, No. 4, 2016
        • TB Notes, No. 3, 2016
        • TB Notes, No. 2, 2016
        • TB Notes, No. 1, 2016
      • Pamphlets, Brochures, Bookletsplus icon
        • Questions and Answers
        • Patient Education Series
        • Tuberculosis – Get the Facts
        • Tuberculosis – The Connection between TB and HIV
        • 12-Dose Regimen for Latent TB Infection-Patient Education Brochure
      • Postersplus icon
        • Mantoux Tuberculin Skin Test Wall Chart
        • World TB Day
        • Think TB
        • Stop TB
        • Take on TB
      • Reports & Articlesplus icon
        • DTBE Authored Journal Articles
        • Tuberculosis Laboratory Aggregate Reports
      • Slide Setsplus icon
        • Introduction to Tuberculosis
        • Epidemiology of Tuberculosis Among Non-U.S.​–Born Persons in the United States, 1993–2016
        • Self-Study Modules on Tuberculosis, 1-5 Slide Sets
        • The Tuberculosis (TB) in Correctional Settingsplus icon
          • Facilitator Guide
        • Introduction to TB Genotyping
        • Epidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2017
        • Prevention and Control of Tuberculosis in Correctional and Detention Facilities
        • Guidelines for Preventing the Transmission of M. TB in Health care Settings
        • Investigation of Contacts of Persons with Infectious TB
        • Epidemiology of Pediatric Tuberculosis in the United States
        • Targeted Tuberculosis Testing and Treatment of Latent Tuberculosis Infection
      • Electronic Tools & Resources
      • Web-Based Courses & Webinarsplus icon
        • TB 101 for Health Care Workers
        • Interactive Core Curriculum
      • Content Syndication
      • Infographicsplus icon
        • Social Media Graphics
        • Customizable Take on TB Infographic with Instructions
    • Events
    • World TB Dayplus icon
      • Digital Toolkit
      • U.S. TB Championsplus icon
        • 2022 CDC U.S. TB Elimination Champions
        • 2021 CDC U.S. TB Elimination Champions
        • 2020 CDC U.S. TB Elimination Champions
        • 2019 CDC U.S. TB Elimination Champions
        • 2018 CDC U.S. TB Elimination Champions
        • 2017 CDC U.S. TB Elimination Champions
        • 2016 CDC U.S. TB Elimination Champions
      • Events
      • History
    • Featuresplus icon
      • TB Risk Factors
      • Treating Latent TB Infection with Short-Course Regimens
      • World Tuberculosis (TB) Day 2021
      • World Tuberculosis (TB) Day 2020
    • Linksplus icon
      • State TB Control Offices
    • About Usplus icon
      • Mission Statement and Activitiesplus icon
        • DTBE Strategic Plan
        • National TB Program Objectives
      • Organization Chart
      • Advisory Groupsplus icon
        • Federal TB Task Force
    email_03Subscribe to get TB updates

    To receive email updates about this page, enter your email address:

    What's this?
    HAVE QUESTIONS?
    Visit CDC-INFO
    Call 800-232-4636
    Email CDC-INFO
    Open 24/7
    CDC INFORMATION
    • About CDC
    • Jobs
    • Funding
    • Policies
    • File Viewers & Players
    • Other Languages
    • Privacy
    • FOIA
    • No Fear Act
    • OIG
    • Nondiscrimination
    • Accessibility
    • Vulnerability Disclosure Policy | Español
    CONNECT WITH CDC
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    • Snapchat

    • Youtube
    • Syndicate
    • CDC TV
    • RSS
    • Email
    CONTACT CDC
    Visit CDC-INFO
    Call 800-232-4636
    Email CDC-INFO
    Open 24/7
    ABOUT CDC
    • About CDC
    • Jobs
    • Funding
    POLICIES
    • Policies
    • File Viewers & Players
    • Other Languages
    • Privacy
    • FOIA
    • No Fear Act
    • OIG
    • Nondiscrimination
    • Accessibility
    • Vulnerability Disclosure Policy | Español
    • CDC Website Exit Disclaimer external icon
    LANGUAGE ASSISTANCE
    • Español
    • 繁體中文
    • Tiếng Việt
    • 한국어
    • Tagalog
    • Русский
    • العربية
    • Kreyòl Ayisyen
    • Français
    • Polski
    • Português
    • Italiano
    • Deutsch
    • 日本語
    • فارسی
    • English
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    • Snapchat
    • Youtube
    • Syndicate
    • CDC TV
    • RSS
    • Email
    U.S. Department of Health & Human Services
    USA.gov
    CDC Website Exit Disclaimer external icon
    • Facebook
    • Twitter
    • LinkedIn
    SAS stats

    Exit Notification / Disclaimer Policy

    Links with this icon indicate that you are leaving the CDC website.
    • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
    • Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
    • You will be subject to the destination website's privacy policy when you follow the link.
    • CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
    For more information on CDC's web notification policies, see Website Disclaimers.